Variation in US Private Health Plans’ Coverage of Orphan Drugs
Health plans restrict orphan drug coverage less often than nonorphan drug coverage. However, the frequency of restrictions varies considerably across plans.
Inflammatory Bowel Disease Readmissions Are Associated With Utilization and Comorbidity
Thirty-day readmissions related to inflammatory bowel disease are common and associated with longer length of stay and a higher likelihood of having an associated comorbid condition compared with index hospitalizations.
The Long-term Social Value of Granulocyte Colony-Stimulating Factors
Although currently underutilized, granulocyte colony-stimulating factor prophylaxis as supportive cancer care provides substantial value to society. Aligning utilization with clinical guidelines would increase this value considerably.
A Deep Learning Model for Pediatric Patient Risk Stratification
Artificial intelligence based on medical claims data outperforms traditional models in stratifying patient risk.
Low Screening and Follow-up for Unhealthy Alcohol Use Among Health Plan Beneficiaries
Screening and follow-up for unhealthy alcohol use are low among plan members. Use of standardized screening tools, documentation, and care for alcohol misuse need improvement.
Real-World Outcomes Among Patients With Early Rapidly Progressive Rheumatoid Arthritis
This study suggests that lower healthcare resource use and achieving low disease activity are associated with first-line abatacept compared with a first-line tumor necrosis factor-α inhibitor for patients with early rapidly progressive rheumatoid arthritis.